|
Trials Starting With "C" |
CACAF: Catheter Ablation for the Cure of Atrial Fibrillation Study
-Trial Overview by Dr. Emanuele Bertaglia (ACC 2005)
CADILLAC: Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications Trial
-Abciximab & Bare Metal Stending in STEMI
-CADILLAC Trial vs. ADMIRAL Trial
-CADILLAC 6 Months by Dr. Gregg Stone
CAMELOT: Comparison of Amlodipine vs. Enalapril to Limit Occurrences of Thrombosis
-CAMELOT/NORMALISE Review by Dr. Steven Nissen
CANPAP: Continuous Positive Airway Pressure for Heart Failure Patients with Central Sleep Apnea
-Trial Overview by Dr. Douglas Bradley (ACC 2005)
CAPITAL AMI: Combined Angiopalsty and Pharmacological Intervention Versus Thrombolytics Alone in Acute Myocardial Infarction Trial
-Trial Overview by Dr. Michel R. Le May (ACC 2004)
CAPTIM: Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction
-One-Year Results (AHA 2002)
CAPTURE: C7E3 Fab Anti-Platelet Therapy in Unstable Refractory Angina
Cardiac memory distinguishes between new and old left bundle branch block:
-Cardiac memory distinguishes between new and old left bundle branch block by Dr. Alexei Shvilkin
CARE: Cardiac Angiography in REnally impaired patients
CARE: Cholesterol And Recurrent Events Trial
-The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels by Dr. Frank Sacks (1996)
CARE-HF: Cardiac Resynchronization Heart Failure Study
-Trial Overview by Dr. John G. Cleland (ACC 2005)
CARISMA: Cardiac Arrhythmias and Risk Stratification after Myocardial Infarction
-Long-term Cardiac Arrhythmias Recorded by Insertable Loop Recorders in Patients with Depressed Left Ventricular Function after Acute Myocardial Infarction by Dr. PE Block Thomsen
CathPCI Registry:
CEREA-DES: Cortisone Plus BMS or DES versus BMS Alone to Eliminate Restenosis
-A Prospective Randomzied Trial of Corticosteroids in Patients Undergoing Stent Implantation by Dr. Flavio Ribichini (TCT 2009)
CHAMP: Cardiac Hospitalization Atherosclerosis Management Program
-Rationale and Design of CHAMP by Dr. Gregg Fonarow and Dr. Anna Gawlinski
CHARISMA: Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance
-Trial Overview by Dr. Deepak L. Bhatt (ACC 2006)
-Trial Overview by Dr. Eric J. Topol (2006) Portuguese
-CHARISMA: The "CAPRIE-like" Cohort by Dr. Deepak L. Bhatt
-Genomics Substudy Results by Dr. Deepak L. Bhatt
CHARM: Candesartan Cilexitil [Atacand™] in Heart Failure Assessment of Reduction Mortality and Morbidity
-Candesartan in Heart Failure European Society of Cardiology 2003
CIBIS III: Cardiac Insufficiency Bisoprolol Study III
-Trial Overview by Dr. Ronnie Willenheimer (European Society of Cariology 2005)
CLARIDI: Cholesterol Lowering and Arrhythmias Recurrences after Internal Defibrillator Implantation Trial
-Trial Overview by Dr. Johan De Sutter (Heart Rhythm Society Meeting 2006)
CLARITY - TIMI 28: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction 28
CLASSICS: Clopidogrel [Plavix™] Aspirin Stent International Cooperative Study
CLEAR PLATELETS IB Study: Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets-IB
CLEAR PLATELETS-2: Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets-2
-Bivalirudin With and Without Eptifibatide for Elective Stenting: A Pharmacodynamic Study of Platelet Reactivity in Relation to the Occurrence of Periprocedural Myocardial Infarction by Dr. Paul A. Gurbel
COCTAIL:
Optimal Treatment of Intracoronary Thrombosis with Local Abciximab Infusion Through the Clearway System
-Trial Overview by Dr. Francesco Prati (TCT 2009)
COGENT: A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel
-Results by Dr. Deepak L. Bhatt (TCT 2009)
COMET: Carvedilol or Metoprolol European Trial
-Trial Overview European Heart Failure Meeting 2003
COMMIT/CCS-2: Clopidogrel and Metoprolol in Myocardial Infarction Trial
-Perspective on COMMIT/CCS-2 Trial of Metoprolol in STEMI by Dr. Christopher Cannon (ACC 2005)
Comparison of the Short-Term Survival Benefit Associated with Revascularization Compared with Medical Therapy in Patients with No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography
COMPASS - HF: Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure
-Trial Overview by Dr. Robert C. Bourge (ACC 2005)
CONSENSUS I: Coorperative North Scandinavian Enalapril Survival Study
CONTRAST: Contrast Media Nephrotoxicity Following Coronary Revascularization by Angioplasty
-Randomized Clinical Trial to Compare the Nephrotoxic Effects of Iso-Osmolar vs. Low-Osmolar Contrast Medium in Patients with Impaired Renal Function Undergoing PCI European Society of Cardiology 2003
Contrast Induced Nephropathy: Sodium Bicarbonate for the Prevention of Contrast Induced Nephropathy
-A Meta-Analysis of Published Clinical Trials by Dr. Vijayalakshmi Kunadian, Dr. Azfar Zaman, and Dr. Weiliang Qiu
COOL RCN: Cooling to Prevent Radiocontrast Nephropathy
-A Prospective, Randomized Trial Examining the Safety and Efficacy of Systemic Hypothermia for the Prevention of Radiocontrast Nephropathy by Dr. Gregg W. Stone (TCT 2008)
CORONA: Controlled Rosuvastatin Multinational Trial in Heart Failure
-Trial Overview by Dr. Ake Hjalmarson (AHA 2007)
Couma-Gen Study: Randomized Trial of Genotype-guided versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation
-A Randomized Trial of Genotype-guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation by JL Anderson, MD (AHA 2007)
COURAGE: Clinical Outcomes Utilizing Revascularization And Aggressive Guideline-Driven Drug Evaluation
-Trial Overview by William E. Boden Spanish
-Economic Results of the COURAGE Trial by Dr. William S. Weintraub
-Angioplasty: A Reality Check! What Does Evidence Based Medicine Tell Us? by Dr. Duane S. Pinto
-Outcomes by Dr. William E. Boden
COURAGE Trial Nuclear Substudy: Clinical Outcomes Utilizing Revascularization & Aggressive Guideline-Driven Drug Evaluation Nuclear Substudy
-The "Truth and Consequences" of Objective Ischemia: The COURAGE Trial Nuclear Substudy
COURAGE Trial Nuclear Substudy II: Clinical Outcomes Utilizing Revascularization & Aggressive Guideline-Driven Drug Evaluation Nuclear Substudy II
CREATE: The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation
CREATE-ECLA: The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation - Estudios Cardiológicos Latinoamérica
-Impact of Low-Molecular-Weight Heparin (Reviparin) on Mortality, Reinfarction, and Stroke in Patients with Acute MI by Dr. S.D. Yusuf (AHA 2004)
-9-month Angiographic an 12-month Clinical Results by Dr. Yaling Han (ACC 2008)
CREATE-ECLA-GIK : The Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation - Estudios Cardiológicos Latinoamérica - Glucose-Insulin-Potassium
-No Improvement in 30-day Mortality with High-Dose Glucose-Insulin-Potassium (GIK) Infusion
CREDO: Clopidogrel for the Reduction of Events During Observation
CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines
-A CRUSADE to Improve Quality of Care for ACS Patients by Dr. Eric D. Peterson
-Management of Patients with NSTE ACS Latest Insights from CRUSADE by Dr. Eric D. Peterson (ACC 2005)
-What Have We Learned from the CRUSADE Registry? by Dr. Eric D. Peterson
-The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results from CRUSADE by Dr. Bimal R. Shah
-2006 CRUSADE 2nd Quarter Results
-MAINTAIN CRUSADE: Medication Applied and Sustained Over Time A Longitudinal Follow-Up Study of the CRUSADE Quality Improvement Initiative
-CRUSADE/ACTION Update by Dr. Eric D. Peterson (ACC 2006)
-Results from the CRUSADE Quality Improvement Initiative Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease
-Results from the CRUSADE Quality Improvement Initiative Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes
C-SIRIUS: The Canadian Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions
CURE: Clopidogrel in Unstable Angina to Prevent Recurrent Events
-Primary Outcome Stratified by TIMI Risk Score
CURRENT OASIS-7: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent Events/Optimal Antiplatelet Strategy for Interventions
-A 2x2 Factorial Randomized Trial of Optimal Clopidogrel and Aspirin Dosing in Patients with ACS Undergoing an Early Invasive Strategy with Intent for PCI by Dr. Shamir R. Mehta
CYPHER Stent Fracture: An Uncommon Complication after "Ultra" Complex PCI
-CYPHER Stent Fracture: An Uncommon Complication after "Ultra" Complex PCI by Dr. Jeffrey J. Popma
Who Are We? Slide Downloading Policy Financial Disclosure We Do Not Promote Off Label Product Use Copyright Source of Slides Editorial Policy Links Policy Privacy Policy Access CME Programs test
© 1999-2009 by Clinical Trial Results .org. None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results. All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster